Pharmaceutical Product Supply – Pseudoephedrine Hydrochloride Tablets
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract entails the manufacture and supply of Pseudoephedrine Hydrochloride Tablets that fully comply with FDA regulations, under CLIN 0001, with an absolute requirement for zero tolerance in quantity variance, ensuring precise adherence to ordered volumes. The product is being procured as a subcontract under the Defense Logistics Agency, part of the Department of Defense, for use in military or federal healthcare applications, with North American Industry Classification System code 325412 indicating pharmaceutical manufacturing as the primary industry. The agreement is scheduled for performance through the Defense Logistics Agency’s procurement framework, with the contract award linked to SPE2DX25D9900 and delivery order SPE2DP26F7740, indicating its alignment with a larger defense supply chain initiative. While specific performance location and point of contact details are not provided, the contract’s strict compliance and quantity controls underscore its critical nature in ensuring consistent, regulated medication availability. The posting date of July 17, 2026, reflects a future anticipated award timeline, and the zero variance stipulation highlights the non-negotiable precision demanded in dosing and batch fulfillment.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
